search
Back to results

Feasibility of the Overground Bodyweight Supporting Walking System Andago

Primary Purpose

Gait Disorders, Neurologic, Cerebral Palsy, Stroke

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Andago
Treadmill
Sponsored by
University Children's Hospital, Zurich
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional device feasibility trial for Gait Disorders, Neurologic focused on measuring Andago, Feasibility, Pediatric Neurorehabilitation

Eligibility Criteria

undefined - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Neuromotor or orthopaedic disorders
  • taller than 135 cm
  • able to understand simple instructions
  • able to walk 10 meters with or without walking aid
  • maximal age of 18 years (a minimal age is not defined as according to the growth curve, children younger than 7-8 years cannot be included because of insufficient height)
  • given informed consent.

Exclusion Criteria:

  • not consolidated fractures or bone fragility of the lower extremities
  • skin lesions in the harness' area which cannot be protected
  • unstable hip, knee and/or ankle Joints
  • reduced head control or inability to maintain an upright Position
  • inability to communicate discomfort or pain
  • surgery in the last 3 months
  • newly implanted baclofen-pump (or children highly sensitive to it)
  • implanted pacemakers
  • passive knee extension deficit > 30°
  • self-selected walking speed > 3.2 km/h.
  • weight > 135 kg
  • height > 2 m.

Sites / Locations

  • Rehabilitation Center of the University Children's Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Andago

Treadmill

Arm Description

Application of walking over-ground with body-weight support in the Andago

Application of walking on a treadmill with body-weight support

Outcomes

Primary Outcome Measures

Stride to stride variability
Variability in stride length recorded during at least 20 steps for each of the following conditions: Andago with reference bodyweight support; Andago with 15% more bodyweight support; Andago with 30% more bodyweight support; and treadmill condition with reference bodyweight support

Secondary Outcome Measures

Leg muscle activity
Amplitude of electromyographic recordings recorded during at least 20 steps for each of the following conditions: Andago with reference bodyweight support; Andago with 15% more bodyweight support; Andago with 30% more bodyweight support; and treadmill condition with reference bodyweight support
Leg joint angles
Joint angles recorded with electrogoniometers during at least 20 steps for each of the following conditions: Andago with reference bodyweight support; Andago with 15% more bodyweight support; Andago with 30% more bodyweight support; and treadmill condition with reference bodyweight support

Full Information

First Posted
April 23, 2018
Last Updated
April 17, 2019
Sponsor
University Children's Hospital, Zurich
Collaborators
Lions Club Zürich-Witikon, Mäxi Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT03787199
Brief Title
Feasibility of the Overground Bodyweight Supporting Walking System Andago
Official Title
Feasibility of the Overground Bodyweight Supporting Walking System Andago
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
May 28, 2018 (Actual)
Primary Completion Date
March 19, 2019 (Actual)
Study Completion Date
March 21, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Children's Hospital, Zurich
Collaborators
Lions Club Zürich-Witikon, Mäxi Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The overall aim of this project is to investigate the clinical utility of the Andago System, a CE certified mobile bodyweight supporting walking robot, in children with neuromotor disorders. Clinical utility encompasses practicability, acceptability, appropriateness, and accessibility. In this study, the investigators would like to investigate several aspects of clinical utility that belong to the first three components.
Detailed Description
The specific aims of the current project are: To investigate the practicability, the investigators plan to determine the accuracy of the weight-supporting system of the Andago and the time needed for donning and doffing. The investigators also evaluate the number of times that the device stops and the nature of these stops (due to errors, sitting of the patient, when preventing falls, or when the patient moves too fast). To evaluate acceptability, the investigators plan to evaluate differences in motivation and measures reflecting safety (i.e. number of falls prevented) and subjective feeling of safety when patients walk with the Andago compared to walking with their usual walking aids. To evaluate the appropriateness, the investigators are interested in differences between walking on a treadmill and walking overground with this device or changes that occur during walking overground when changing the level of BWS through the unloading system. Therapists should be aware of these differences to know what the advantage of such a system could be or how adjustments in settings influence the walking pattern. The investigators plan two investigations: (a) To determine differences in stride-to-stride variability, leg muscle activation, hip, knee and ankle joint kinematics and other gait parameters during walking in the Andago (overground) versus walking on a treadmill. (b) To determine differences in the same parameters when walking in the Andago with different levels of BWS. These levels are the minimal required level of BWS to walk without buckling the knees (ref BWS), ref BWS plus 15% and ref BWS plus 30%. To investigate these aims, the patients will be asked to participate in 3 appointments, which should be scheduled within 10 days.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gait Disorders, Neurologic, Cerebral Palsy, Stroke, Traumatic Brain Injury, Child, Only, Gait Disorders in Children
Keywords
Andago, Feasibility, Pediatric Neurorehabilitation

7. Study Design

Primary Purpose
Device Feasibility
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Feasibility study, including a comparison between Andago and treadmill walking conditions (as we include a heterogeneous group of participants concerning age (children/adolescents), diagnosis, walking ability, etc., we include in this feasibility study 20 participants - rather than the usual 10). Patients participate in 3 appointments (planned within 10 days): Appointment 1 (60 min): patient characteristics, clinical tests (Selective Control Assessment of the Lower Extremity / Manual Muscle Testing / 10 meter walk test or 10MWT); practising on treadmill and in Andago; questions to participants Appointment 2 (45 min): determine accuracy of the unloading system; practicing on treadmill and in Andago; questions to participant Appointment 3 (60-90 min): 10MWT at onset and end; measurement of stride length, leg muscle EMG and joint kinematics during walking on treadmill with bodyweight unloading and walking overground with Andago with 3 levels of bodyweight unloading
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Andago
Arm Type
Experimental
Arm Description
Application of walking over-ground with body-weight support in the Andago
Arm Title
Treadmill
Arm Type
Active Comparator
Arm Description
Application of walking on a treadmill with body-weight support
Intervention Type
Device
Intervention Name(s)
Andago
Intervention Description
The Andago is a body-weight supporting device with which a patient can walk overground
Intervention Type
Other
Intervention Name(s)
Treadmill
Intervention Description
Bodyweight supported treadmill walking
Primary Outcome Measure Information:
Title
Stride to stride variability
Description
Variability in stride length recorded during at least 20 steps for each of the following conditions: Andago with reference bodyweight support; Andago with 15% more bodyweight support; Andago with 30% more bodyweight support; and treadmill condition with reference bodyweight support
Time Frame
Appointment 3 (between minute 25 and minute 55 )
Secondary Outcome Measure Information:
Title
Leg muscle activity
Description
Amplitude of electromyographic recordings recorded during at least 20 steps for each of the following conditions: Andago with reference bodyweight support; Andago with 15% more bodyweight support; Andago with 30% more bodyweight support; and treadmill condition with reference bodyweight support
Time Frame
Appointment 3 (between minute 25 and minute 55 )
Title
Leg joint angles
Description
Joint angles recorded with electrogoniometers during at least 20 steps for each of the following conditions: Andago with reference bodyweight support; Andago with 15% more bodyweight support; Andago with 30% more bodyweight support; and treadmill condition with reference bodyweight support
Time Frame
Appointment 3 (between minute 25 and minute 55)
Other Pre-specified Outcome Measures:
Title
Bodyweight unloading [kg]
Description
Comparison of bodyweight unloading according to Andago device compared to actual bodyweight unloading measured with scales [kg]
Time Frame
Data are obtained during Appointment 2 (between minute 1 and minute 10)
Title
Number of device stops
Description
Number of Andago device stops measured throughout the habituation periods during appointments 1 and 2
Time Frame
Data are obtained during Appointment 1 between minute 25 and minute 45 and Appointment 2 between minute 10 to 30
Title
Customized questionnaire investigating acceptability [dichotomous]
Description
Participant is being asked whether the patient prefers treadmill or Andago (dichotomous outcome: 0=treadmill/1=Andago), and if the patient would like to train again in the Andago (0=no/1=yes). No sum score is calculated.
Time Frame
At the end of Appointments 1 (between minute 55-58) and the end of Appointment 2 (between minute 40-43)
Title
Questionnaire acceptability [visual analogue scale]
Description
How much fun was it training in the Andago? [score 0=no fun at all to 10=maximal amount of fun]
Time Frame
At the end of Appointments 1 (between minute 59-60) and the end of Appointment 2 (between minute 44-45)
Title
Time needed for donning and doffing [seconds]
Description
Time in seconds needed for mounting the patient in the Andago and, at the end of walking in the Andago, the time needed to get the patient out of the device
Time Frame
During Appointment 1 (mounting around minute 25; taking off around minute 43) and Appointment 2 (mounting around minute 1; taking off around minute 28)
Title
Manual Muscle Testing (MMT)
Description
Manual muscle testing is performed for providing a characterization of the patients. For each muscle group, a score is given between 0 (no visible or palpable contraction) and 5 (patient moves over the full range of motion against gravity with additional maximal resistance). The following muscles will be tested: hip flexors and extensors; hip inner- and outer-rotators; knee flexors and extensors; ankle plantar and dorsal flexors
Time Frame
Appointment 1 between minute 1 and 5
Title
Selective Control Assessment of the Lower Extremity (SCALE)
Description
The SCALE assesses the selectivity of lower extremity joints. It provides a score between 0 (not able) and 2 (normal selectivity) for each of the following joints: hip, knee, ankle, subtalar joint, and toes. It provides a sum score for the left and right leg separately (0= not able; 10= normal selectivity) and an overall sum score (0=not able; 20=normal selectivity)
Time Frame
Appointment 1 between minute 6 and 15 minutes
Title
Active and passive Range of Motion (ROM) of leg joints
Description
Active (by patient) and passive (by therapist) mobility of the hip, knee and ankle joints are made in the sagittal plane. The ROM is noted according to the neutral zero method (degrees). ROM testing is performed for providing a characterization of the patients.
Time Frame
Appointment 1 between minute 16 and 20 minutes
Title
10 meter walk test
Description
Children walk 14 meters; intermediate 10 meters is time stopped to calculate the walking speed
Time Frame
Appointments 1 between minute 21 and 25 and Appointment 3 between minute 1 and 5 and 56 and 60

10. Eligibility

Sex
All
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Neuromotor or orthopaedic disorders taller than 135 cm able to understand simple instructions able to walk 10 meters with or without walking aid maximal age of 18 years (a minimal age is not defined as according to the growth curve, children younger than 7-8 years cannot be included because of insufficient height) given informed consent. Exclusion Criteria: not consolidated fractures or bone fragility of the lower extremities skin lesions in the harness' area which cannot be protected unstable hip, knee and/or ankle Joints reduced head control or inability to maintain an upright Position inability to communicate discomfort or pain surgery in the last 3 months newly implanted baclofen-pump (or children highly sensitive to it) implanted pacemakers passive knee extension deficit > 30° self-selected walking speed > 3.2 km/h. weight > 135 kg height > 2 m.
Facility Information:
Facility Name
Rehabilitation Center of the University Children's Hospital
City
Affoltern Am Albis
State/Province
Zurich
ZIP/Postal Code
8910
Country
Switzerland

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
We have to check with the local ethics committee whether our pseudonymized data can be shared
Citations:
PubMed Identifier
33557834
Citation
van Hedel HJA, Rosselli I, Baumgartner-Ricklin S. Clinical utility of the over-ground bodyweight-supporting walking system Andago in children and youths with gait impairments. J Neuroeng Rehabil. 2021 Feb 8;18(1):29. doi: 10.1186/s12984-021-00827-1.
Results Reference
derived

Learn more about this trial

Feasibility of the Overground Bodyweight Supporting Walking System Andago

We'll reach out to this number within 24 hrs